![](/img/cover-not-exists.png)
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response
Charpentier, C., Lee, G. Q., Rodriguez, C., Visseaux, B., Storto, A., Fagard, C., Molina, J.-M., Katlama, C., Yazdanpanah, Y., Harrigan, P. R., Descamps, D.Language:
english
Journal:
Journal of Antimicrobial Chemotherapy
DOI:
10.1093/jac/dkv048
Date:
March, 2015
File:
PDF, 363 KB
english, 2015